Rothschild Investment LLC’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.87K | Sell |
205
-225
| -52% | -$2.05K | ﹤0.01% | 2129 |
|
|
2025
Q1 | $3.42K | Buy |
430
+270
| +169% | +$2.15K | ﹤0.01% | 1616 |
|
|
2024
Q4 | $869 | Buy |
160
+130
| +433% | +$706 | ﹤0.01% | 2291 |
|
|
2024
Q3 | $217 | Sell |
30
-240
| -89% | -$1.74K | ﹤0.01% | 2701 |
|
|
2024
Q2 | $2.93K | Buy |
270
+15
| +6% | +$163 | ﹤0.01% | 1291 |
|
|
2024
Q1 | $4.78K | Buy |
255
+5
| +2% | +$94 | ﹤0.01% | 1140 |
|
|
2023
Q4 | $5.42K | Buy |
+250
| New | +$5.42K | ﹤0.01% | 1070 |
|